+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Topical Drug Delivery Market Research Report by End-User, by Rout to Administration, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

  • ID: 4829843
  • Report
  • July 2021
  • Region: Global
  • 189 pages
  • 360iResearch™
UP TO OFF
until Sep 30th 2021
The Global Topical Drug Delivery Market will Grow to USD 140.01 Billion by 2026, at a CAGR of 6.66%

FEATURED COMPANIES

  • Absorption Systems LLC
  • Bayer AG
  • Cipla Limited
  • GlaxoSmithKline plc
  • MedPharm Ltd.
  • Merck & Co., Inc.
  • MORE
The Global Topical Drug Delivery Market size was estimated at USD 95.08 Billion in 2020 and expected to reach USD 101.10 Billion in 2021, at a Compound Annual Growth Rate (CAGR) 6.66% to reach USD 140.01 Billion by 2026.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Topical Drug Delivery to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on End-User, the Topical Drug Delivery Market was studied across Burn Centers, Home Care Settings, and Hospitals and Clinics.
  • Based on Product, the Topical Drug Delivery Market was studied across Liquid Formulations, Semi-Solid Formulations, Solid Formulations, and Transdermal Products. The Liquid Formulations is further studied across Solutions and Suspensions. The Semi-Solid Formulations is further studied across Creams, Gels, Lotions, Ointments, and Pastes. The Solid Formulations is further studied across Powders and Suppositories. The Transdermal Products is further studied across Transdermal Patches and Transdermal Semi-Solids.
  • Based on Rout to Administration, the Topical Drug Delivery Market was studied across Dermal Drug Delivery, Nasal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery, and Vaginal Drug Delivery.
  • Based on Region, the Topical Drug Delivery Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Topical Drug Delivery Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Topical Drug Delivery Market, including Absorption Systems LLC, Bausch Health Companies Inc, Bayer AG, Cipla Limited, Crescita Therapeutics Inc., GlaxoSmithKline plc, Glenmark Pharmaceuticals Limited, Hisamitsu Pharmaceutical Co., Inc., Janssen Global Services, LLC, MedPharm Ltd., Merck & Co., Inc., Mylan N.V., Nestlé S.A., Novartis International AG, and The Lubrizol Corporation.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Topical Drug Delivery Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Topical Drug Delivery Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Topical Drug Delivery Market?
4. What is the competitive strategic window for opportunities in the Global Topical Drug Delivery Market?
5. What are the technology trends and regulatory frameworks in the Global Topical Drug Delivery Market?
6. What is the market share of the leading vendors in the Global Topical Drug Delivery Market?
7. What modes and strategic moves are considered suitable for entering the Global Topical Drug Delivery Market?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Absorption Systems LLC
  • Bayer AG
  • Cipla Limited
  • GlaxoSmithKline plc
  • MedPharm Ltd.
  • Merck & Co., Inc.
  • MORE
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
3.1. Introduction
3.2. Market Outlook
3.3. End-User Outlook
3.4. Product Outlook
3.5. Rout to Administration Outlook
3.6. Region Outlook
3.7. Competitor Outlook

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. High prevalence of skin diseases
5.1.1.2. Rising prevalence of eye diseases
5.1.1.3. High incidence of burn injuries
5.1.1.4. Increasing prevalence of diabetes
5.1.2. Restraints
5.1.2.1. Preference for alternative modes of drug delivery
5.1.3. Opportunities
5.1.3.1. Delivery of biologics through the transdermal route
5.1.3.2. Self-administration and home care
5.1.4. Challenges
5.1.4.1. Technical barriers related to skin irritation and permeability
5.1.4.2. Drug failures and product recalls
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry

6. Topical Drug Delivery Market, by End-User
6.1. Introduction
6.2. Burn Centers
6.3. Home Care Settings
6.4. Hospitals and Clinics

7. Topical Drug Delivery Market, by Product
7.1. Introduction
7.2. Liquid Formulations
7.2.1. Solutions
7.2.2. Suspensions
7.3. Semi-Solid Formulations
7.3.1. Creams
7.3.2. Gels
7.3.3. Lotions
7.3.4. Ointments
7.3.5. Pastes
7.4. Solid Formulations
7.4.1. Powders
7.4.2. Suppositories
7.5. Transdermal Products
7.5.1. Transdermal Patches
7.5.2. Transdermal Semi-Solids

8. Topical Drug Delivery Market, by Rout to Administration
8.1. Introduction
8.2. Dermal Drug Delivery
8.3. Nasal Drug Delivery
8.4. Ophthalmic Drug Delivery
8.5. Rectal Drug Delivery
8.6. Vaginal Drug Delivery

9. Americas Topical Drug Delivery Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Topical Drug Delivery Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Thailand

11. Europe, Middle East & Africa Topical Drug Delivery Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion

13. Company Usability Profiles
13.1. Absorption Systems LLC
13.2. Bausch Health Companies Inc
13.3. Bayer AG
13.4. Cipla Limited
13.5. Crescita Therapeutics Inc.
13.6. GlaxoSmithKline plc
13.7. Glenmark Pharmaceuticals Limited
13.8. Hisamitsu Pharmaceutical Co., Inc.
13.9. Janssen Global Services, LLC
13.10. MedPharm Ltd.
13.11. Merck & Co., Inc.
13.12. Mylan N.V.
13.13. Nestlé S.A.
13.14. Novartis International AG
13.15. The Lubrizol Corporation

14. Appendix
14.1. Discussion Guide
14.2. License & Pricing

List of Figures
FIGURE 1. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, 2020 VS 2026 (USD BILLION)
FIGURE 2. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2020 (USD BILLION)
FIGURE 3. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2020 (USD BILLION)
FIGURE 4. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2020 (USD BILLION)
FIGURE 5. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY REGION, 2020 (USD BILLION)
FIGURE 6. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 7. GLOBAL TOPICAL DRUG DELIVERY MARKET: MARKET DYNAMICS
FIGURE 8. GLOBAL TOPICAL DRUG DELIVERY MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 9. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2020 VS 2026 (%)
FIGURE 10. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2020 VS 2026 (USD BILLION)
FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2026
FIGURE 12. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY BURN CENTERS, 2018-2026 (USD BILLION)
FIGURE 13. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY BURN CENTERS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 14. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY HOME CARE SETTINGS, 2018-2026 (USD BILLION)
FIGURE 15. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 16. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2026 (USD BILLION)
FIGURE 17. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 18. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2020 VS 2026 (%)
FIGURE 19. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2020 VS 2026 (USD BILLION)
FIGURE 20. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2026
FIGURE 21. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2026 (USD BILLION)
FIGURE 22. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 23. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLUTIONS, 2018-2026 (USD BILLION)
FIGURE 24. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLUTIONS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 25. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY SUSPENSIONS, 2018-2026 (USD BILLION)
FIGURE 26. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY SUSPENSIONS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 27. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2026 (USD BILLION)
FIGURE 28. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 29. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY CREAMS, 2018-2026 (USD BILLION)
FIGURE 30. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY CREAMS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 31. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY GELS, 2018-2026 (USD BILLION)
FIGURE 32. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY GELS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 33. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY LOTIONS, 2018-2026 (USD BILLION)
FIGURE 34. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY LOTIONS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 35. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY OINTMENTS, 2018-2026 (USD BILLION)
FIGURE 36. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY OINTMENTS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 37. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY PASTES, 2018-2026 (USD BILLION)
FIGURE 38. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY PASTES, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 39. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2026 (USD BILLION)
FIGURE 40. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 41. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY POWDERS, 2018-2026 (USD BILLION)
FIGURE 42. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY POWDERS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 43. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY SUPPOSITORIES, 2018-2026 (USD BILLION)
FIGURE 44. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY SUPPOSITORIES, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 45. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2026 (USD BILLION)
FIGURE 46. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 47. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PATCHES, 2018-2026 (USD BILLION)
FIGURE 48. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PATCHES, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 49. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL SEMI-SOLIDS, 2018-2026 (USD BILLION)
FIGURE 50. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL SEMI-SOLIDS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 51. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2020 VS 2026 (%)
FIGURE 52. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2020 VS 2026 (USD BILLION)
FIGURE 53. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2026
FIGURE 54. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY DERMAL DRUG DELIVERY, 2018-2026 (USD BILLION)
FIGURE 55. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY DERMAL DRUG DELIVERY, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 56. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY NASAL DRUG DELIVERY, 2018-2026 (USD BILLION)
FIGURE 57. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY NASAL DRUG DELIVERY, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 58. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY OPHTHALMIC DRUG DELIVERY, 2018-2026 (USD BILLION)
FIGURE 59. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY OPHTHALMIC DRUG DELIVERY, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 60. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY RECTAL DRUG DELIVERY, 2018-2026 (USD BILLION)
FIGURE 61. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY RECTAL DRUG DELIVERY, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 62. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY VAGINAL DRUG DELIVERY, 2018-2026 (USD BILLION)
FIGURE 63. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY VAGINAL DRUG DELIVERY, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 64. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 65. ARGENTINA TOPICAL DRUG DELIVERY MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 66. BRAZIL TOPICAL DRUG DELIVERY MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 67. CANADA TOPICAL DRUG DELIVERY MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 68. MEXICO TOPICAL DRUG DELIVERY MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 69. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 70. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 71. AUSTRALIA TOPICAL DRUG DELIVERY MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 72. CHINA TOPICAL DRUG DELIVERY MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 73. INDIA TOPICAL DRUG DELIVERY MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 74. INDONESIA TOPICAL DRUG DELIVERY MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 75. JAPAN TOPICAL DRUG DELIVERY MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 76. MALAYSIA TOPICAL DRUG DELIVERY MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 77. PHILIPPINES TOPICAL DRUG DELIVERY MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 78. SINGAPORE TOPICAL DRUG DELIVERY MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 79. SOUTH KOREA TOPICAL DRUG DELIVERY MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 80. THAILAND TOPICAL DRUG DELIVERY MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 81. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 82. FRANCE TOPICAL DRUG DELIVERY MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 83. GERMANY TOPICAL DRUG DELIVERY MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 84. ITALY TOPICAL DRUG DELIVERY MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 85. NETHERLANDS TOPICAL DRUG DELIVERY MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 86. QATAR TOPICAL DRUG DELIVERY MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 87. RUSSIA TOPICAL DRUG DELIVERY MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 88. SAUDI ARABIA TOPICAL DRUG DELIVERY MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 89. SOUTH AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 90. SPAIN TOPICAL DRUG DELIVERY MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 91. UNITED ARAB EMIRATES TOPICAL DRUG DELIVERY MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 92. UNITED KINGDOM TOPICAL DRUG DELIVERY MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 93. GLOBAL TOPICAL DRUG DELIVERY MARKET: FPNV POSITIONING MATRIX
FIGURE 94. GLOBAL TOPICAL DRUG DELIVERY MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 95. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL TOPICAL DRUG DELIVERY MARKET, BY TYPE

List of Tables
TABLE 1. GLOBAL TOPICAL DRUG DELIVERY MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 4. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2026 (USD BILLION)
TABLE 5. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY BURN CENTERS, BY REGION, 2018-2026 (USD BILLION)
TABLE 6. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2026 (USD BILLION)
TABLE 7. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2026 (USD BILLION)
TABLE 8. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2026 (USD BILLION)
TABLE 9. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, BY REGION, 2018-2026 (USD BILLION)
TABLE 10. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLUTIONS, BY REGION, 2018-2026 (USD BILLION)
TABLE 11. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY SUSPENSIONS, BY REGION, 2018-2026 (USD BILLION)
TABLE 12. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, BY REGION, 2018-2026 (USD BILLION)
TABLE 13. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY CREAMS, BY REGION, 2018-2026 (USD BILLION)
TABLE 14. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY GELS, BY REGION, 2018-2026 (USD BILLION)
TABLE 15. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY LOTIONS, BY REGION, 2018-2026 (USD BILLION)
TABLE 16. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY OINTMENTS, BY REGION, 2018-2026 (USD BILLION)
TABLE 17. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY PASTES, BY REGION, 2018-2026 (USD BILLION)
TABLE 18. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, BY REGION, 2018-2026 (USD BILLION)
TABLE 19. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY POWDERS, BY REGION, 2018-2026 (USD BILLION)
TABLE 20. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY SUPPOSITORIES, BY REGION, 2018-2026 (USD BILLION)
TABLE 21. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, BY REGION, 2018-2026 (USD BILLION)
TABLE 22. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PATCHES, BY REGION, 2018-2026 (USD BILLION)
TABLE 23. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL SEMI-SOLIDS, BY REGION, 2018-2026 (USD BILLION)
TABLE 24. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2026 (USD BILLION)
TABLE 25. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY DERMAL DRUG DELIVERY, BY REGION, 2018-2026 (USD BILLION)
TABLE 26. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY NASAL DRUG DELIVERY, BY REGION, 2018-2026 (USD BILLION)
TABLE 27. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY OPHTHALMIC DRUG DELIVERY, BY REGION, 2018-2026 (USD BILLION)
TABLE 28. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY RECTAL DRUG DELIVERY, BY REGION, 2018-2026 (USD BILLION)
TABLE 29. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY VAGINAL DRUG DELIVERY, BY REGION, 2018-2026 (USD BILLION)
TABLE 30. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 31. ARGENTINA TOPICAL DRUG DELIVERY MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 32. BRAZIL TOPICAL DRUG DELIVERY MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 33. CANADA TOPICAL DRUG DELIVERY MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 34. MEXICO TOPICAL DRUG DELIVERY MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 35. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 36. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 37. AUSTRALIA TOPICAL DRUG DELIVERY MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 38. CHINA TOPICAL DRUG DELIVERY MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 39. INDIA TOPICAL DRUG DELIVERY MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 40. INDONESIA TOPICAL DRUG DELIVERY MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 41. JAPAN TOPICAL DRUG DELIVERY MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 42. MALAYSIA TOPICAL DRUG DELIVERY MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 43. PHILIPPINES TOPICAL DRUG DELIVERY MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 44. SINGAPORE TOPICAL DRUG DELIVERY MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 45. SOUTH KOREA TOPICAL DRUG DELIVERY MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 46. THAILAND TOPICAL DRUG DELIVERY MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 47. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 48. FRANCE TOPICAL DRUG DELIVERY MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 49. GERMANY TOPICAL DRUG DELIVERY MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 50. ITALY TOPICAL DRUG DELIVERY MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 51. NETHERLANDS TOPICAL DRUG DELIVERY MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 52. QATAR TOPICAL DRUG DELIVERY MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 53. RUSSIA TOPICAL DRUG DELIVERY MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 54. SAUDI ARABIA TOPICAL DRUG DELIVERY MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 55. SOUTH AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 56. SPAIN TOPICAL DRUG DELIVERY MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 57. UNITED ARAB EMIRATES TOPICAL DRUG DELIVERY MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 58. UNITED KINGDOM TOPICAL DRUG DELIVERY MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 59. GLOBAL TOPICAL DRUG DELIVERY MARKET: SCORES
TABLE 60. GLOBAL TOPICAL DRUG DELIVERY MARKET: BUSINESS STRATEGY
TABLE 61. GLOBAL TOPICAL DRUG DELIVERY MARKET: PRODUCT SATISFACTION
TABLE 62. GLOBAL TOPICAL DRUG DELIVERY MARKET: RANKING
TABLE 63. GLOBAL TOPICAL DRUG DELIVERY MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 64. GLOBAL TOPICAL DRUG DELIVERY MARKET: MERGER & ACQUISITION
TABLE 65. GLOBAL TOPICAL DRUG DELIVERY MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 66. GLOBAL TOPICAL DRUG DELIVERY MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 67. GLOBAL TOPICAL DRUG DELIVERY MARKET: INVESTMENT & FUNDING
TABLE 68. GLOBAL TOPICAL DRUG DELIVERY MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 69. GLOBAL TOPICAL DRUG DELIVERY MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • Absorption Systems LLC
  • Bausch Health Companies Inc
  • Bayer AG
  • Cipla Limited
  • Crescita Therapeutics Inc.
  • GlaxoSmithKline plc
  • Glenmark Pharmaceuticals Limited
  • Hisamitsu Pharmaceutical Co., Inc.
  • Janssen Global Services, LLC
  • MedPharm Ltd.
  • Merck & Co., Inc.
  • Mylan N.V.
  • Nestlé S.A.
  • Novartis International AG
  • The Lubrizol Corporation
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll